Smartphone-Assisted High-Intensity Interval Training in Inflammatory Rheumatic Disease Patients: Randomized Controlled Trial
Question
Is smartphone-assisted HIIT comparable with supervised HIIT for cardiorespiratory fitness, quality of life, adherence, and safety in inflammatory rheumatic disease patients?
Summary
In screened patients with inflammatory rheumatic disease, app-guided 4 x 4 minute HIIT improved VO2max about as much as supervised HIIT over 10 weeks, with no severe cardiovascular adverse events reported.
Methodology
- Adults with inflammatory rheumatic diseases including rheumatoid arthritis, spondyloarthritis, and systemic lupus erythematosus
- 40 participants.
- Walking or running on treadmill, gym, or uphill outdoor route using Myworkout GO.
- Work intervals: 4 minutes.
- Recovery: 3 minutes active recovery.
- Intensity: RPE 16-17, about 85-95% HRmax; app estimated intensity from speed/incline.
- 34 minutes.
- 2 sessions per week.
- 10 weeks.
- Two-arm randomized controlled trial
- VO2max, Oxygen pulse, Health-related quality of life, and Safety were tracked.
Outcomes
VO2max
Both app-guided and supervised HIIT improved VO2max similarly.
VO2max increased p<0.001; supervised +3.6 +/- 1.3 mL/kg/min and app-guided +3.7 +/- 1.5 mL/kg/min; no between-group difference.
Oxygen pulse
Oxygen pulse improved in both groups.
Time effect p<0.001; no meaningful between-group difference reported.
HRQoL
Several quality-of-life domains improved over time without clear between-group differences.
Bodily pain, vitality, and social functioning improved with p values from <0.001 to 0.04.
Safety
No severe cardiovascular adverse events were reported during testing or HIIT.
Safety events were described narratively; no severe cardiovascular events in either group.
Insights
- A 4 x 4 minute HIIT format can be delivered through a smartphone app in screened inflammatory rheumatic disease patients.
- App delivery may reduce supervision requirements but needs intensity-estimation safeguards.
- Exercise tolerance testing and medical screening were part of the safety context.
Limitations
- Per-protocol analysis rather than full intention-to-treat.
- Motivated volunteer sample.
- App group intensity was not directly heart-rate monitored for all sessions.
- Missing HRQoL data in some app-group participants.
Safety
- No severe cardiovascular adverse events occurred during or after VO2max testing or HIIT. Some withdrawals were related to illness, high disease activity, plantar fasciitis, low-back disc herniation, or knee/ankle inflammation; some were considered possibly training related.